The purpose of this study is to see if it is safe and effective to use fluoxetine to treat
children and adolescents with Generalized Anxiety Disorder (GAD).
Anxiety disorders are one of the most common psychiatric disorders in children and
adolescents, and can cause disturbances in the child's school, social, and family lives.
Having an anxiety disorder puts a child at risk for depression and drug abuse, and appears to
continue into adulthood. There is very little information on anxiety medications for
children.
Children will be assigned randomly (like tossing a coin) to receive either fluoxetine or an
inactive placebo for 12 weeks. Each child will be monitored for symptoms and side effects
throughout the study. He/she will have blood tests at Weeks 4, 8, and 12 to measure drug
levels in the blood. The study will last for 12 weeks.
A child is eligible for this study if he/she:
Is 8 to 17 years old and has anxiety disorder.
A child will not be eligible for this study if he/she:
Has current major depression, panic disorder, or obsessive-compulsive disorder, or abuses
alcohol or drugs.